Silver Book Fact

Life expectancy and quality of life gains from AVR

A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years gained at a net value of $11.2 billion (~$14.2 billion in 2017 dollars).

Wu Y, Grunkmeier G, Starr A. The Value of Aortic Valve Replacement in Elderly Patients: An economic analysis. Journal of Thoracic and Cardiovascular Surgery. 2007; 133(3): 603-7. http://www.jtcvsonline.org/article/S0022-5223(06)01477-2/fulltext

Reference

Title
The Value of Aortic Valve Replacement in Elderly Patients: An economic analysis
Publication
Journal of Thoracic and Cardiovascular Surgery
Publication Date
2007
Authors
Wu Y, Grunkmeier G, Starr A
Volume & Issue
Volume 133, Issue 3
Pages
603-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Improvements in QoL from TAVR in SAS patients
    Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)…  
  • Survival rates of SAS patients ages 80+ with and without SAVR
     
  • TAVR Procedures 2011 – 2015
    From approval in 2011 through 2015, >54,000 transcatheter aortic valve replacements (TAVRs) were performed in 418 centers in 48 states.  
  • In 2010, ~67,500 SAVRs were performed in the U.S.
     
  • Survival Rates of SAS Patients with and without SAVR
    Patients with severe aortic stenosis (SAS) ages 80+ who underwent surgical aortic valve replacement (SAVR) have 1-year, 2-year, and 5-year survival rates of 87%, 78%, and 68% respectively — compared with…